FAES Farma | Spain

Author Profile

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

Publications

📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
Journal: Nutrients
Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
Journal: European Journal of Pharmaceutical Sciences
Year: 2024

📄 Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
Journal: Drugs in R and D
Year: 2024

📄 Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
Journal: PharmacoEconomics
Year: 2023

📄 Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
Journal: Diseases of the Colon and Rectum
Year: 2022

Sejal Parekh | Health Professions | Best Researcher Award

Posted on 27/09/202427/09/2024 by Book of Award

Ms. Sejal Parekh | Health Professions | Best Researcher Award

NHS England | United Kingdom

Author Profile

Orcid

Early Academic Pursuits 📚

Sejal Parekh embarked on her academic journey with a Master of Pharmacy (MPharm) from University College London, where she honed her expertise in pharmaceutical sciences. In 2017, she furthered her education with a Master’s in Clinical Research (MRes), funded by the NIHR. This strong academic foundation in pharmacy and clinical research equipped her with a comprehensive understanding of quantitative and qualitative research methodologies.

Professional Endeavors 💼

Sejal’s career spans diverse roles within both hospital and community pharmacy settings. She has been instrumental in leading national quality improvement initiatives, particularly as a Senior Project/Policy Manager at NHS England. Her role involved developing criteria for the Pharmacy Quality Scheme (PQS) and liaising with stakeholders like NHS Digital, Public Health England, and the Pharmaceutical Services Negotiating Committee (PSNC). Her work, particularly during the pandemic, led to the implementation of infection control measures, influencing community pharmacy operations across the country.

Contributions and Research Focus 🔬

Sejal's contributions are deeply rooted in antimicrobial stewardship, service delivery, and policy writing. A notable project was her leadership in the NSAID safety audit within community pharmacies, where she identified a significant gap in gastroprotection for patients on NSAIDs. Her findings prompted recommendations that improved patient safety in primary care, aligning with the WHO Global Patient Safety Challenge. Sejal has co-authored several reports and articles that are widely recognized within the medical community.

Accolades and Recognition 🏆

Throughout her career, Sejal has received several awards, including:

HSJ Winner: Patient Safety Team of 2023 for her work on the Pharmacy Quality Scheme.
She was also the Pre-registration Trainee Pharmacist of the Year for London (2003) and a GlaxoSmithKline Prize recipient for her work on smoking cessation.

Her accolades underscore her dedication to patient safety and innovative pharmaceutical care.

Impact and Influence 🌍

Sejal's work has had a profound impact on community pharmacy in the UK. Her development of safer prescribing initiatives and infection control protocols, especially during the COVID-19 pandemic, has contributed to national improvements in healthcare delivery. Her ability to collaborate across teams and organizations has resulted in smoother policy implementations and improved patient outcomes.

Legacy and Future Contributions 🌟

As a thought leader in pharmacy, Sejal Parekh’s legacy is built upon her pioneering work in antimicrobial stewardship and patient safety. Her ongoing contributions to the Pharmacy Quality Scheme and national healthcare initiatives demonstrate her commitment to improving service quality. With her recent role as a Programme Manager for NHS England, Sejal is poised to continue making impactful changes in the healthcare landscape. Her future endeavors will likely include further innovations in pharmacy services, ensuring continued excellence in patient care.

Publications

📚 "An Evaluation of Oral Anticoagulant Safety Indicators by England’s Community Pharmacies"
Journal: Pharmacy, Year: 2024
Authors: Sejal Parekh, Lingqian Xu, Carina Livingstone

📚 "Responding to Urinary Tract Infection Symptoms in England’s Community Pharmacies"
Journal: Antibiotics, Year: 2023
Authors: Sejal Parekh, Kieran S Hand, Lingqian Xu, Victoria Roberts, Fionna Pursey, Diane Ashiru-Oredope, Donna Lecky

📚 "The National Implementation of a Community Pharmacy Antimicrobial Stewardship Intervention (PAMSI) through the English Pharmacy Quality Scheme 2020 to 2022"
Journal: Antibiotics, Year: 2023
Authors: Catherine Hayes, Sejal Parekh, Donna Lecky, Jill Loader, Carry Triggs-Hodge, Diane Ashiru-Oredope

📚 "ESPAUR Report 2021 to 2022 Chapter 5: NHS England Improvement and Assurance Schemes"
Journal: Medical Sciences Forum, Year: 2023
Authors: Kieran S Hand, Diane Ashiru-Oredope, Elizabeth Beech, Sabine Bou-Antoun, Gillian Damant, Naomi Fleming, Catherine Hayes, Philip Howard, Conor Jamieson, Monsey McLeod et al.

📚 "National Antimicrobial Stewardship Activities in Primary and Secondary Care in England 2021–22 (ESPAUR Report)"
Journal: Medical Sciences Forum, Year: 2023
Authors: Ella Casale, Catherine Hayes, Donna Lecky, Luke O’Neil, Eirwen Sides, Emily Cooper, Fionna Pursey, Sejal Parekh, Eleanor J. Harvey, Diane Ashiru-Oredope

Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Posted on 28/08/202428/08/2024 by Book of Award

Dr. Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Tzaneio General Hospital of Piraeus | Greece

Aurhor Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Theodoros B. Grivas began his illustrious journey in medicine by graduating from the Medical School at “Aristotle” University of Thessaloniki in 1978. His academic foundation was further solidified through comprehensive training in General Surgery, Paediatric and Adult Orthopaedics, and Traumatology in Greece. Driven by a passion for deepening his expertise, he pursued and earned a Ph.D. from the National and Kapodistrian University of Athens, establishing a robust foundation for his future contributions to orthopaedic and spinal surgery.

💼 Professional Endeavors

Throughout his career, Dr. Grivas worked at prestigious institutions, including the “University Hospital” at Queen’s Medical Centre in Nottingham, “Harlow Wood” Orthopaedic Hospital in Mansfield, UK, and prominent hospitals in Athens, Greece. Notably, he served as the Director of the Orthopaedics and Traumatology Department at “Thriasio” Hospital for five years and later at “Tzaneio” General Hospital of Piraeus for 12 years until his retirement in 2021. His leadership and expertise significantly impacted the field, where he played a pivotal role in advancing patient care and surgical practices.

🔬 Contributions and Research Focus

Dr. Grivas has an impressive record of scientific contributions, including over 645 scientific publications and presentations, with 136 indexed in Medline. His research spans various orthopaedic and spinal topics, with a particular focus on school screening programs and spinal deformities. As a principal investigator or collaborator, he was involved in 20 research projects, funded by national and European sources. Additionally, he established a National Training Center for school-screening examiners and was a key figure in implementing the School Screening program in Greece.

🏆 Accolades and Recognition

Dr. Grivas’s achievements have been recognized both nationally and internationally. He has served as a member and Traveling Fellow of renowned organizations like AAOS, AOA, and SRS. He held the presidency of the IRSSD, SOSORT (which he helped found), and the Hellenic Spine Society. His editorial contributions include serving as the Chief Editor of the BMC open access journal “Scoliosis and Spinal Deformities,” and as a member of the editorial board or a reviewer for several peer-reviewed journals. His department was also honored with the opportunity to provide the “Trialect platform” Fellowship in Orthopaedics and Traumatology.

🌍 Impact and Influence

Dr. Grivas’s influence extends beyond his immediate clinical work, impacting the broader medical community through his involvement in critical decision-making bodies. During 2019-2020, he served on the National Examination Committee for Orthopaedics and Traumatology and was a member of the Crisis and Selection Council of the Hellenic National Health System from 2020-2021, which is responsible for the appointment of Orthopaedic Surgeons in State Hospital Positions.

🚀 Legacy and Future Contributions

Even in retirement, Dr. Grivas continues to contribute to the field he has dedicated his life to. He is currently focused on establishing the Hellenic Scoliosis Foundation, aiming to further advance the understanding and treatment of scoliosis. His enduring legacy lies in his vast body of work, the numerous professionals he has mentored, and the patients whose lives he has improved through his expertise in orthopaedics and spinal surgery. His future contributions promise to leave a lasting impact on the field, continuing to inspire and guide the next generation of surgeons.

Publications

📄 Rib index is a strong surrogate of scoliometric reading in idiopathic scoliosis
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Mamzari, A., Vasiliadis, E.
Journal: European Spine Journal
Year: 2024

📄 Cross-cultural adaptation, reliability and validity of the Greek version of the Spinal Appearance Questionnaire (SAQ) in patients with adolescent idiopathic scoliosis
Author(s): Oikonomaki, M., Kelalis, G., Skouras, A.Z., Georgoudis, G., Grivas, T.
Journal: Spine Deformity
Year: 2024

📄 A Questionnaire of Physiotherapeutic Specific Exercises of Scoliosis—QPSSE
Author(s): Grivas, T.B., Dadakaridou, D., Fokidi, S.A., Theodosopoulos, E., Griva, A.M.
Journal: Journal of Clinical Medicine
Year: 2024

📄 Menarche in Scoliotic and Non-Scoliotic Balkan Girls and the Relationship between Menarche and the Laterality of Scoliotic Curves
Author(s): Pjanic, S., Jevtic, N., Grivas, T.B.
Journal: Journal of Clinical Medicine
Year: 2024

📄 Segmental Rib Index and Spinal Deformity: Scoliogenic Implications
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Golic, F., Vasiliadis, E.
Journal: Healthcare (Switzerland)
Year: 2023

Jyoti Upadhyay | Health Professions | Women Research Award

Posted on 16/02/202416/02/2024 by Book of Award

Dr. Jyoti Upadhyay | Health Professions | Women Research Award

School of Health Sciences and Technology UPES | India

Author Profile

Scopus

Google Scholar

Early Academic Pursuits

Dr. Jyoti Upadhyay pursued her academic journey with a fervor for pharmaceutical sciences. Her Ph.D. from Kumaun University focused on the impact of persistent organic pollutants on birth defects. Earlier, she excelled in her M.Pharm, exploring the interaction between Rhododendron flower juice and amlodipine bioavailability.

Professional Endeavors

With a wealth of experience, Dr. Upadhyay has served in various capacities, including Associate Professor at UPES University and Coordinator at the Adverse Drug Reaction Monitoring Centre. She has also contributed significantly as an Assistant Professor and Research Scholar.

Contributions and Research Focus

Dr. Upadhyay's research spans from investigating birth defect rates to analyzing drug interactions and establishing community resilience centers. She led projects on pharmacognostic investigations and health status surveys in Uttarakhand, showcasing her diverse research interests and commitment to public health.

Accolades and Recognition

Her dedication has earned her numerous accolades, including Academic Excellence and Best Researcher Awards. Additionally, she's been recognized for her outstanding performance in academic pursuits and her contributions to scientific writing.

Impact and Influence

Dr. Upadhyay's work has made a significant impact on pharmaceutical research, public health, and academia. Through her research, teaching, and project leadership, she has influenced the understanding of drug interactions, birth defect risks, and community health resilience.

Legacy and Future Contributions

Dr. Upadhyay's legacy lies in her multifaceted contributions to pharmaceutical sciences and public health. Her future contributions are anticipated to further advance knowledge in pharmacology, drug safety, and community health, leaving a lasting impact on research, education, and societal well-being.

Notable Publications

ECG based apnea detection by multirate processing hybrid of wavelet-empirical decomposition Hjorth features extraction and neural networks 2023

Degradation of Xenobiotic Pollutants: An Environmentally Sustainable Approach 2022 (21)

In vivo wound-healing and antioxidant activity of aqueous extract of Roylea elegans leaves against physically induced burn model in Wistar albino rats 2021 (4)

Nina Tuncel | Health Professions | Women Research Award

Posted on 07/02/202407/02/2024 by Book of Award

Assoc Prof Dr. Nina Tuncel | Health Professions | Women Research Award

Akdeniz University | Turkey

Author Profile

Scopus

Early Academic Pursuits

Assoc. Prof. Nina Tunçel began her academic journey with a solid foundation in physics at Al-Zahra University, Iran, where she completed her undergraduate studies from 1979 to 1987. She pursued postgraduate studies in Tıbbi Radyofizik at Istanbul University's Health Sciences Institute from 1988 to 1991, followed by a doctoral degree in the same field from 1991 to 1998. Her academic pursuits in physics laid the groundwork for her interdisciplinary research focus encompassing medicine, health sciences, and biophysics.

Professional Endeavors

Throughout her career, Assoc. Prof. Nina Tunçel has held various academic and professional positions, demonstrating her commitment to advancing knowledge and expertise in her field. She began as a Research Assistant at Istanbul University's Onkoloji Enstitüsü (Oncology Institute) from 1993 to 1996, marking the beginning of her involvement in medical physics research. Subsequently, she held positions as an Expert at Akdeniz University's Faculty of Medicine and Dokuz Eylul University's Tıp Fakültesi (Faculty of Medicine) , where she contributed significantly to radiation oncology and internal medicine.

Contributions and Research Focus

Assoc. Prof. Tunçel's research areas span a wide range of disciplines, including medicine, health sciences, internal medicine sciences, radiation oncology, physics, and interdisciplinary physics. Her expertise in biophysics and medical physics has led to numerous contributions in the understanding and application of radiation in healthcare, such as the design of tissue-mimicking gel phantoms for diffusion kurtosis imaging and the optimization of radiotherapy techniques for various cancer treatments. Her research has been published in prestigious journals indexed by SCI, SSCI, and AHCI, highlighting her significant contributions to the scientific community.

Accolades and Recognition

Assoc. Prof. Nina Tunçel has received recognition for her outstanding contributions to the field of medical physics. Her research has earned her accolades such as the Best Researcher Award, demonstrating the impact of her work on advancing knowledge and innovation in healthcare. Additionally, she has been acknowledged for her academic excellence through publications in renowned journals and presentations at international conferences, further solidifying her reputation as a leading expert in her field.

Impact and Influence

Assoc. Prof. Tunçel's work has had a profound impact on the field of medical physics, particularly in the areas of radiation oncology and biophysics. Her research has contributed to the development of innovative techniques and methodologies for cancer treatment, improving the effectiveness and precision of radiation therapy while minimizing adverse effects on patients. Through her academic endeavors and professional contributions, she has inspired future generations of scientists and clinicians to explore new frontiers in medical physics and contribute to the advancement of healthcare.

Legacy and Future Contributions

Assoc. Prof. Nina Tunçel's legacy lies in her significant contributions to the field of medical physics, which have paved the way for advancements in cancer treatment and radiation therapy. Her research has provided invaluable insights into the complex interactions between radiation and biological systems, leading to improved patient outcomes and quality of life. As she continues her academic journey, Assoc. Prof. Tunçel remains committed to pushing the boundaries of knowledge in medical physics and shaping the future of healthcare through her innovative research and dedication to excellence.

Notable Publications

Physical and chemical properties of beads glasses 2023

Radio-sensitivity on MCF-7 cells of silver nanoparticles synthesized by Silybum marianum 2023 (3)

Hybrid Tomo-Helical and Tomo-Direct radiotherapy for localized prostate cancer 2021 (1)

The dose rate measurements of C-arm fluoroscopic x-ray systems with and without apron 2018 (1)

Design and Characterisation of Tissue-Mimicking Gel Phantoms for Diffusion Kurtosis Imaging 2018 (17)

Bantalem Tilaye Atinafu |Nursing and Health Professions | Editorial Board Member

Posted on 30/01/202430/01/2024 by Book of Award

Mr. Bantalem Tilaye Atinafu | Nursing and Health Professions | Editorial Board Member

Debre Berhan University, Debre Berhan | Ethiopia

Author Profile

Google Scholar

Early Academic Pursuits

Bantalem Tilaye Atinafu embarked on his academic journey with a Bachelor's degree in Nursing at Debre Berhan University. His passion for healthcare and education motivated him to pursue a Master's in Adult Health Nursing at Addis Ababa University, where he excelled with a remarkable 3.91 GPA, showcasing his commitment to academic excellence.

Professional Endeavors

Joining Debre Berhan University as a Lecturer, Bantalem dedicated himself to teaching and learning. His role extended beyond the classroom, contributing to the ethical review board, department council committees, and actively guiding both undergraduate and postgraduate students. His leadership expanded further as the Head Nurse in the Medicine Department at Hakim Gizaw Specialized Hospital, where he oversees various healthcare aspects.

Contributions and Research Focus

Bantalem's impactful contributions span teaching, research, and community service. As a research enthusiast, he has been actively engaged in numerous projects, with several publications in prestigious peer-reviewed journals. His commitment extends to community service through initiatives like student tutoring, first aid training, and grassroots soccer programs.

Accolades and Recognition

Bantalem's academic achievements, including his stellar GPA in Master's studies, stand as a testament to his dedication. His active involvement in research projects has garnered recognition within academic and professional circles.

Impact and Influence

Bantalem's influence is evident in his multifaceted roles – from shaping young minds as a lecturer to leading healthcare initiatives as a department head. His research outputs contribute to the broader academic and healthcare communities, leaving a lasting impact.

Legacy and Future Contributions

Bantalem's legacy lies in his holistic approach to education, healthcare, and community service. With a track record of achievements, he continues to inspire future healthcare professionals and researchers. His vision includes furthering impactful research and expanding community-oriented initiatives, leaving an enduring legacy in nursing and health professions.

Notable Publications

Prevalence and risk factors of malnutrition among adult cancer patients receiving chemotherapy treatment in cancer center, Ethiopia: Cross-sectional study 2021 (21)

Survival Status and Predictors of Mortality Among Colorectal Cancer Patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Retrospective Follow-up Study 2020 (11)

Magnitude of Anxiety and Depression and Associated Factors among Palliative Care Patients with Cancer at Tikur Anbessa Specialized Hospital, Ethiopia 2022 (4)